The global Coronary Stents Market is projected to reach a substantial USD 51.2 billion by 2032, reflecting a steady growth ...

Kawasaki disease (KD), an acute self-limited febrile illness that primarily affects children <5 years old, is the leading cause of acquired heart disease in developed countries, with the potential of ...

A “bioadaptive” stent might circumvent the slow accumulation of target lesion failure that has been a consistent weakness of ...

The change reflects a growing understanding of what resources are needed to offer these scans and will likely improve access.

Importantly, 11 of these loci are specific to AS and show no association with coronary artery disease (CAD), highlighting the ...

On World Heart Day, Dr. Praveen Chandra highlights the dangers of cardiovascular diseases beyond heart attacks.

In MI patients with preserved heart function, beta-blockers are linked to higher depressive symptoms, indicating a need for ...

The global coronary artery bypass graft market, valued at USD 17,612.1 million in 2023, is forecast to experience significant growth, reaching an estimated USD 22,765.9 million by 2033. While the ...

A history of HDP is linked to increased risks of myocardial infarction, whether that’s with obstructive coronary arteries or ...

The estimated Industrial Analysis of Coronary Stent in India in 2023 is USD 843.8 million. The need for less invasive methods ...

NEW HOPE, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact ...